RPTX
Price
$1.87
Change
-$2.10 (-52.90%)
Updated
Dec 13, 01:28 PM (EDT)
81 days until earnings call
VIR
Price
$7.41
Change
-$0.02 (-0.27%)
Updated
Dec 13, 02:10 PM (EDT)
69 days until earnings call
Ad is loading...

RPTX vs VIR

Header iconRPTX vs VIR Comparison
Open Charts RPTX vs VIRBanner chart's image
Repare Therapeutics
Price$1.87
Change-$2.10 (-52.90%)
Volume$4.86K
CapitalizationN/A
Vir Biotechnology
Price$7.41
Change-$0.02 (-0.27%)
Volume$890
CapitalizationN/A
RPTX vs VIR Comparison Chart
Loading...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RPTX vs. VIR commentary
Dec 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTX is a Hold and VIR is a Buy.

COMPARISON
Comparison
Dec 13, 2024
Stock price -- (RPTX: $3.97 vs. VIR: $7.43)
Brand notoriety: RPTX and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RPTX: 384% vs. VIR: 111%
Market capitalization -- RPTX: $168.77M vs. VIR: $1.02B
RPTX [@Biotechnology] is valued at $168.77M. VIR’s [@Biotechnology] market capitalization is $1.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $494.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RPTX’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 0 green FA rating(s).

  • RPTX’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 0 green, 5 red.
According to our system of comparison, VIR is a better buy in the long-term than RPTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RPTX’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • RPTX’s TA Score: 5 bullish, 5 bearish.
  • VIR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both RPTX and VIR are a good buy in the short-term.

Price Growth

RPTX (@Biotechnology) experienced а +33.67% price change this week, while VIR (@Biotechnology) price change was -6.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.11%. For the same industry, the average monthly price growth was -3.32%, and the average quarterly price growth was +7.36%.

Reported Earning Dates

RPTX is expected to report earnings on Mar 04, 2025.

VIR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-3.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.02B) has a higher market cap than RPTX($169M). VIR YTD gains are higher at: -26.143 vs. RPTX (-45.616). RPTX has higher annual earnings (EBITDA): -90.24M vs. VIR (-562.68M). VIR has more cash in the bank: 914M vs. RPTX (179M). RPTX has less debt than VIR: RPTX (2.56M) vs VIR (113M). RPTX has higher revenues than VIR: RPTX (66.5M) vs VIR (62M).
RPTXVIRRPTX / VIR
Capitalization169M1.02B17%
EBITDA-90.24M-562.68M16%
Gain YTD-45.616-26.143174%
P/E RatioN/AN/A-
Revenue66.5M62M107%
Total Cash179M914M20%
Total Debt2.56M113M2%
TECHNICAL ANALYSIS
Technical Analysis
RPTXVIR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMRGX7.02-0.01
-0.14%
Emerging Markets Growth Fund M
HLMOX8.13-0.04
-0.49%
Harding Loevner Frontier Emerg Mkts Inv
ABSYX27.85-0.23
-0.82%
American Beacon Small Cp Val Y
HLMRX17.43-0.20
-1.13%
Harding Loevner Intl Small Coms Instl
RYWUX55.90-3.28
-5.54%
Rydex Emerging Markets 2X Strategy C

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with VIR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+10.28%
VIR - RPTX
44%
Loosely correlated
-4.99%
PGEN - RPTX
42%
Loosely correlated
-5.09%
ARCT - RPTX
40%
Loosely correlated
-2.23%
ALNY - RPTX
38%
Loosely correlated
-3.50%
AXON - RPTX
37%
Loosely correlated
-0.94%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with ADPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-4.99%
ADPT - VIR
49%
Loosely correlated
-3.45%
AVIR - VIR
49%
Loosely correlated
-0.34%
CRSP - VIR
48%
Loosely correlated
-4.98%
AXON - VIR
47%
Loosely correlated
-0.94%
TECH - VIR
45%
Loosely correlated
-0.17%
More